Subtopic Deep Dive

Adherence to Antineoplastic Safety Guidelines
Research Guide

What is Adherence to Antineoplastic Safety Guidelines?

Adherence to antineoplastic safety guidelines measures compliance with NIOSH and ASHP standards in handling cytotoxic drugs through audits, surveys, and training assessments.

Studies evaluate healthcare workers' adherence to guidelines like ASHP (Köhler et al., 2002, 120 citations) and ASCO/ONS (Jacobson et al., 2009, 117 citations). Surveys reveal gaps in knowledge and practices among oncology nurses (Asefa et al., 2021, 41 citations). Over 20 papers since 2002 analyze barriers and interventions.

Curated Papers

Key Challenges

Why It Matters

Adherence reduces occupational exposure risks like skin rashes, infertility, and cancer from antineoplastic drugs (Bos et al., 2004, 49 citations). Ethiopian oncology nurses showed inadequate safe handling practices despite training, with married nurses scoring higher on knowledge (Asefa et al., 2021). ASHP guidelines identify medication errors in compounding and administration, enabling targeted interventions that lower contamination rates 100-fold when prepared in pharmacies versus clinics (Larmené-Beld et al., 2019, 50 citations).

Key Research Challenges

Knowledge Gaps in Nurses

Oncology nurses at tertiary hospitals lack sufficient knowledge on cytotoxic drug handling despite guidelines (Asefa et al., 2021). Surveys show inadequate PPE use and training. Interventions must address marital status correlations with practice scores.

Training Inconsistency

ASHP and ASCO/ONS standards exist but implementation varies across institutions (Köhler et al., 2002; Jacobson et al., 2009). Audits reveal persistent non-compliance. Standardized education programs are needed.

Environmental Contamination Risks

Clinical preparation yields higher microbial contamination than pharmacy settings (Larmené-Beld et al., 2019). NIOSH warnings highlight exposure to hazardous drugs (Bos et al., 2004). Barrier identification requires audits.

Essential Papers

ASHP Guidelines on Preventing Medication Errors with Antineoplastic Agents

David Köhler, Michael Montello, Barry R. Goldspiel et al. · 2002 · American Journal of Health-System Pharmacy · 120 citations

Journal Article ASHP Guidelines on Preventing Medication Errors with Antineoplastic Agents Get access David R. Kohler, Pharm.D., David R. Kohler, Pharm.D. Search for other works by this author on: ...

American Society of Clinical Oncology/Oncology Nursing Society Chemotherapy Administration Safety Standards

Joseph O. Jacobson, Martha Polovich, Kristen K. McNiff et al. · 2009 · Journal of Clinical Oncology · 117 citations

Standardization of care can reduce the risk of errors, increase efficiency, and provide a framework for best practice. In 2008, the American Society of Clinical Oncology (ASCO) and the Oncology Nur...

APSIC guidelines for disinfection and sterilization of instruments in health care facilities

Moi Lin Ling, Patricia Ching, Ammar Widitaputra et al. · 2018 · Antimicrobial Resistance and Infection Control · 89 citations

Abstract Background The Asia Pacific Society of Infection Control launched its revised Guidelines for Disinfection and Sterilization of Instruments in Health Care Facilities in February 2017. This ...

Mesothelin-targeting T cell receptor fusion construct cell therapy in refractory solid tumors: phase 1/2 trial interim results

Raffit Hassan, Marcus O. Butler, Roisin E. O’Cearbhaill et al. · 2023 · Nature Medicine · 88 citations

Designing packaging to support the safe use of medicines at home

James Ward, Peter Buckle, P. John Clarkson · 2010 · Applied Ergonomics · 69 citations

A systematic review and meta-analysis of microbial contamination of parenteral medication prepared in a clinical versus pharmacy environment

Karin H. M. Larmené‐Beld, Henderik W. Frijlink, Katja Taxis · 2019 · European Journal of Clinical Pharmacology · 50 citations

Significantly higher contamination rates were found for the preparation of parenteral medication in the clinical environment compared to pharmacy environment. In accordance with recent guidance, th...

Preventing occupational exposures to antineoplastic and other hazardous drugs in health care settings.

R Bos, Pjm Sessink, S Burgaz et al. · 2004 · 49 citations

Warning!Working with or near hazardous drugs in health care settings may cause skin rashes, infertility, miscarriage, birth defects, and possibly leukemia or other cancers.The National Institute fo...

Reading Guide

Foundational Papers

Start with Köhler et al. (2002) for ASHP error prevention guidelines and Jacobson et al. (2009) for ASCO/ONS administration standards, as they define core compliance metrics cited 237 times total.

Recent Advances

Study Asefa et al. (2021) for nurse knowledge surveys and Larmené-Beld et al. (2019) for contamination meta-analysis, revealing real-world gaps post-guidelines.

Core Methods

Surveys and audits (Asefa et al., 2021); meta-analyses of contamination rates (Larmené-Beld et al., 2019); guideline checklists from NIOSH/ASHP (Bos et al., 2004).

How PapersFlow Helps You Research Adherence to Antineoplastic Safety Guidelines

Discover & Search

Research Agent uses searchPapers for 'adherence antineoplastic guidelines audits' retrieving Asefa et al. (2021), then citationGraph maps connections to Köhler et al. (2002) with 120 citations, and findSimilarPapers expands to 50+ compliance studies. exaSearch uncovers NIOSH-related surveys.

Analyze & Verify

Analysis Agent applies readPaperContent to extract adherence rates from Asefa et al. (2021), verifyResponse with CoVe checks claims against Jacobson et al. (2009), and runPythonAnalysis computes meta-analysis of contamination odds ratios from Larmené-Beld et al. (2019) using pandas. GRADE grading scores evidence from surveys as moderate quality.

Synthesize & Write

Synthesis Agent detects gaps like training inconsistencies across Bos et al. (2004) and Asefa et al. (2021), flags contradictions in PPE efficacy, and uses exportMermaid for compliance workflow diagrams. Writing Agent employs latexEditText for audit reports, latexSyncCitations to integrate 20 papers, and latexCompile for publication-ready PDFs.

Use Cases

"What are adherence rates to NIOSH guidelines in oncology nursing?"

Research Agent → searchPapers + citationGraph on Asefa et al. (2021) → Analysis Agent → runPythonAnalysis (pandas meta-analysis of survey data) → researcher gets CSV of pooled adherence percentages (e.g., 60% PPE compliance).

"Draft LaTeX review on ASHP guideline compliance gaps."

Synthesis Agent → gap detection across Köhler et al. (2002) → Writing Agent → latexEditText + latexSyncCitations + latexCompile → researcher gets compiled PDF with 15 cited papers and figures.

"Find code for analyzing antineoplastic exposure audit data."

Research Agent → paperExtractUrls from Larmené-Beld et al. (2019) → Code Discovery → paperFindGithubRepo + githubRepoInspect → researcher gets Python scripts for contamination rate stats.

Automated Workflows

Deep Research workflow conducts systematic review: searchPapers 50+ adherence papers → DeepScan 7-step analysis with GRADE checkpoints on Asefa et al. (2021) → structured report on barriers. Theorizer generates intervention hypotheses from Köhler et al. (2002) and Bos et al. (2004) gaps. Chain-of-Verification ensures zero hallucinations in compliance meta-analyses.

Try Doxa for Adherence to Antineoplastic Safety Guidelines Research

Frequently Asked Questions

What defines adherence to antineoplastic safety guidelines?

Compliance with NIOSH, ASHP (Köhler et al., 2002), and ASCO/ONS (Jacobson et al., 2009) standards via audits measuring PPE use, compounding hygiene, and spill management.

What methods assess adherence?

Surveys of knowledge/practices (Asefa et al., 2021), environmental audits for contamination (Larmené-Beld et al., 2019), and observational checklists against guidelines.

What are key papers?

Foundational: Köhler et al. (2002, 120 citations), Jacobson et al. (2009, 117 citations). Recent: Asefa et al. (2021, 41 citations), Larmené-Beld et al. (2019, 50 citations).

What open problems exist?

Persistent training gaps despite guidelines (Asefa et al., 2021); need for institution-specific interventions; validating pharmacy vs. clinical contamination reductions at scale (Larmené-Beld et al., 2019).